TrialInternational urogynecology journal2024

Injection site number and outcomes of intradetrusor onabotulinumtoxinA for refractory overactive bladder syndrome: a randomized clinical trial.

Anna Zdroik et al.PubMed ↗Publisher ↗

No numbers read from the abstract.